Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote in favor of your Number one Kind of Gems - 2Overseeing Individual budgets Successfully
- 3China bans storing cremated remains in empty 'bone ash apartments'
- 4Former Peruvian President Pedro Castillo sentenced for conspiracy
- 5Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- Grasping the Basics of Business Land Regulation
- Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
- Two UN peacekeepers killed in explosion in Lebanon
- The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior
- Find the Effect of Web-based Entertainment on Psychological wellness: Exploring the Advanced Scene Securely
- Which Startup's Innovation Could Reform Medical care?
- Israel halts defense sales to France, citing 'hostile attitude,' sources tell 'Post'
- What's The Friendliest City In The United Kingdom?
- Home Machine Basics: An Exhaustive Purchasing Guide
